Chemotherapy Combination Regimens for Acute Leukemia 1994.2.23

Chemotherapy Combination Regimens for Acute Leukemia 1994.2.23

1. Acute Non-Lymphocytic Leukemia (ANLL)

Using daunorubicin and cytarabine (DA regimen), the complete remission rate can reach 61.7%. Daunorubicin (DNR) is administered at 40mg daily for 1–3 days via intravenous drip; cytarabine is given at 100mg daily, divided into two doses—one in the morning and one in the evening—and can be taken orally, injected intramuscularly, or infused intravenously, with two doses being optimal, for 1–7 days.

2. Acute Lymphocytic Leukemia (ALL)

Using vincristine, prednisone, daunorubicin, and cyclophosphamide (VPDC regimen). Vincristine is 2mg once a week; daunorubicin is 40mg once a week for 1–3 times; cyclophosphamide is 600mg once a week; prednisone is 40–60mg daily, divided into three doses. Note that the dose of daunorubicin (DNR) is 40mg daily, administered 1–3 times a week.